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Radiation burden of patients undergoing
endovascular abdominal aortic aneurysm repair
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Dimitris Dristiliaris, MSc,a Lampros K. Michalis, MD,c and Miltiadis Matsagas, MD,b Ioannina, Greece
Introduction: Endovascular repair of abdominal aortic aneurysm (EVAR) requires the patient’s extended exposure to x-rays,
before, during, and after the intervention. The aim of this study was to determine the radiation exposure of patients
undergoing EVAR and to assess the probability for the induction of both late and early radiation-related effects.
Methods: During the period of May 2006 to December 2007 EVAR was carried out in 62 patients using a mobile C-arm
unit. The following dosimetric quantities were assessed: fluoroscopy time, cumulative dose in air, dose-area product, field
area, and peak skin dose.
Results: The duration of fluoroscopy and the body mass index were found to be the main factors that influence the
radiation burden in our hospital. The mean effective dose per procedure, 6.2 mSv, was between that from a planar
coronary angiography and a coronary angioplasty. Taking into account the computed tomography (CT) procedure-
related angiographies carried out during the first year, patients receive a total effective dose of about 62 mSv within the
first year. In vivo dosimetry showed that the peak skin dose was linearly correlated with cumulative dose in air and did not
exceed 1.0 Gy, ie, it was less than the threshold for any acute skin reaction.
Conclusion: Repair of abdominal aortic aneurysm results in substantial radiation burden. Radiation-related risks for
carcinogenesis and skin injuries are factors that have to be taken into account in the selection of the strategy of each
facility. ( J Vasc Surg 2009;49:283-7.)Fluoroscopy-guided therapeutic procedures, such as
endovascular aneurysm repair, are an essential part of the
contemporary practice in medicine. A drawback of these
procedures is the associated radiation risk. Taking into
account that complications may appear even many years
after endovascular aneurysm repair of the abdominal aorta
(EVAR), the life-long follow-up often includes computed
tomography (CT) imaging, a modality that requires a sub-
stantial radiologic burden. Therefore, the assessment of the
corresponding radiologic burden to the patient and the
definition of the steps required to keep it as low as reason-
ably achievable is one of the many prerequisites for the
choice of the optimum treatment strategy in each facility.
In addition, almost anything that helps to reduce patient
exposure will also reduce staff exposure.
Health effects induced by ionizing radiations, such as
x-rays, can be divided into two categories: (1) stochastic
effects, ie, induction of cancer in exposed individuals and
heritable diseases in their offspring (so far, there is no direct
evidence that in humans exposure of parents to radiation
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deterministic or non-stochastic effects (tissue reactions),
observable only if the dose is above some threshold.
In radiologic protection, stochastic effects are widely
assumed related with DNA damage response processes in
single cells. Protection measures are employed under the
assumption that the probability of induction of such effects
in an organ or tissue is directly proportional to the mean
dose absorbed in the irradiated organ or tissue (the quo-
tient of absorbed energy to the organ or tissue to its mass,
expressed in Gy, J/kg) with no dose threshold (“linear-
non-threshold” model). The quantity effective dose (as-
sessed in mSv), defined as the weighted mean value of the
doses absorbed in a number of organs or tissues,1,2 is widely
used as an estimator of the radiologic risk related to sto-
chastic effects (7.3% per Sv for the whole population).2
However, taking into account the age-dependent radiosen-
sitivity and the time interval between exposure and possible
clinical appearance of these effects, the age distribution of
the exposed patients and their health status should to be
taken into consideration. For example, the life expectancy
of patients with an aortic aneurysm drastically reduces the
probability of clinical manifestations of some types of can-
cer,1,2 as well as the induction of heritable diseases.
Deterministic effects, sometimes also called tissue reac-
tions, are due in a large part to killing/malfunction of many
cells in an organ or tissue following doses above a specific
dose threshold. Early harmful tissue reactions can be in-
flammatory-type reactions as a result of cell permeability
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thema, seen in skin a few hours after a dose of at least 2 Gy
from x-rays within a short time period when the exposed
area of the skin is relatively large.1-5 The threshold of
temporary epilation and the main erythematous reaction,
whose onset is after approximately 10 days, are larger, 3 and
6 Gy, respectively.4 The induction of more severe effects,
such as dermal atrophy, necrosis, and desquamation, that
are related to cell loss, can be induced by even higher skin
doses. Taking into account the threshold values of the
organ and tissues irradiated directly during EVAR, peri-
procedure imaging, and the rapid attenuation of the diag-
nostic x-ray beams inside the human body, a peak dose less
than 2 Gy in any skin area within a short time period can
exclude the induction of serious harmful deterministic
EVAR-related effects in men and non-pregnant women.
The aim of this study was to determine the radiation
exposure of patients undergoing EVAR and to assess the
corresponding radiologic risks. Reduction in the patient’s
radiation burden during fluoroscopically-guided interven-
tions usually results in a reduction of the staff radiation
burden.
MATERIALS AND METHODS
Patients – EVAR. During the period of May 2006 to
December 2007, 62 EVAR consecutive procedures were
carried out in at the Ioannina University Hospital (IUH) in
62 patients (60 male and 2 female, Table I). The mean age
and body mass index (BMI) of the patients were 74-years-
old (range, 50-87-years-old) and 28.9 kg/m2 (range,
21-40 kg/m2), respectively. All repairs were carried out by
one of the authors (M.M.) assisted by another certified
vascular surgeon and a trainee. A young medical physicist
was also physically present in the operation theater during
some of the procedures. The procedures were performed
using a mobile C-arm unit BV Libra (Philips, Best, The
Netherlands). The unit used is equipped with a 3.15 kW
generator, a 6.35mmAleq filter (1.5mmAl 0.1mmCu),
an iris-type collimator, and a 9” image intensifier. Both the
tube current and high voltage were selected automatically
in each mode and their mean values during the continuous
low dose rate mode used for fluoroscopy in the present
study, were 3.1 mA and 81 kV, respectively, corresponding
to a 5.3 mm Al half-value layer of the x-ray beam. During
the procedure, the x-ray source was placed under a surgical
table (Getinge, AlphaMaxx, Rochester, NY).
Dosimetry-EVAR. The dosimetric data were ob-
Table I. Patients’ characteristics (n  62)
Parameter Age (years)
Diameter of the
aneurysm (cm)
Bod
Mean value 74.0 6.4 1
Median 75.0 6.2 1
Standard deviation 7.1 1.2
Range of values 50-87 4.8-11.5 15tained and analyzed by scientists of the IUH MedicalPhysics Laboratory (J.K-E., D.D., and K.D.). More specif-
ically, the following quantities from the C-arm unit were
registered: (1) duration of fluoroscopy, t; (2) dose-area
product (DAP), sometimes also called air-kerma area prod-
uct, a quantity related to the total number of photons
emitted from the x-ray unit; (3) cumulative absorbed dose
in air, D, at a 69.5 cm distance from the x-ray source (30 cm
from the detector) with no patient in place (free-in-air
geometry).
The ratio of the last two quantities, DAP/D, ie, the
area of the radiation field at a distance 70 cm from the x-ray
source, was calculated.
A low sensitivity Kodak X-Omat V radiographic film
(Eastman Kodak Co, Rochester, NY), 14”  17”, was
positioned between the patient’s body and the mattress to
document the sizes and the locations of the radiation fields
at the patient’s skin, assess the source to skin distance, and
provide an immediate qualitative assessment of spatial skin-
dose distribution. The film did not add discomfort to the
patient lying on the film for extended procedure times,
since it does not have to be in a rigid cassette. The reduction
of the skin dose due to the presence of the radiographic film
along the beam path was neglected in the present study.
The possibility of exceeding a threshold for induction
of a deterministic effect was based on peak skin dose assess-
ment. For this reason, the cumulative doses absorbed in air
were correlated with the peak skin doses assessed by in vivo
measurements in a subgroup of patients. The empirical
relationship between the directly measured peak skin doses
Fig. Peak skin dose assessed by in vivo dosimetry vs cumulative
dose in air. TLD, thermoluminescent dosimeters.
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of patients. More specific, in vivo dose measurements on the
patient’s backwere carried out during the EVARprocedure in
5 randomly chosen patients using individually calibrated LiF:
Mg,Ti thermoluminescent dosimeters (TLDs) and aHarshaw
3500 reader (Harshaw-Global, Solon, Ohio). Thirty-two do-
simeters divided into eight groups were positioned between
the radiographic film and the patient’s back forming an array
30 cm–long along the patient’s spine. Optical density mea-
surements of the radiographic film were used to confirm the
adequate coverage of the patient’s back to identify the
location of the peak skin dose. A known radiation dose was
given in 12 TLDs. The remaining six were not irradiated
and were used to determine the background signal.
In the current study, the 1990 definition of the effec-
tive dose by the International Commission on Radiological
Protection was used, that takes into account the ratio of the
energy absorbed in 22 organs or tissues to the organ or
tissue mass.2 The effective dose to DAP ratio proposed by
Geijer et al,6 0.145 mSv/Gy cm2, was used for the calcu-
lation of the effective dose in all patients, despite the fact
that the exact value depends among other things on the
anatomic location of the aneurysm to be treated, beam
penetration (mainly depended on beam filtration and the
automatically selected kV), and body-build.
A Philips MX8000 IDT CT unit (Philips Medical Sys-
tems, Cleveland, Ohio) equipped with 24 rows of detectors
was used for preoperative planning and post-EVAR surveil-
lance (120 kV, 200 mA, 1 second, reconstruction collima-
tion 16  1.5 mm, pitch 1.2, and current modulation
according to the body habitus). The effective dose was
calculated using the ImPACT CT Patient Dosimetry Cal-
culator (version 0.99v) (ImPACT, London, UK) based on
Computed TomographyDose Indexmeasurements carried
in air and a pencil-type ionization chamber. The skin dose
to the patient’s back was assessed using thermoluminescent
dosimetry.
RESULTS
EVAR procedure. The quantity DAP was linearly
correlated with fluoroscopy time, and BMI (n  62, r 
0.90, standard error of estimate (SEE)  13.6).
DAP Gy cm248 1.44 t (minutes)
 1.92 BMI kg m2
About 22% of the entire DAP value was related to
image registration, while the remaining to fluoroscopy.
Taking into account that a 42.5 Gy cm2 mean DAP value
was found (range, 9 and 139 Gy cm2, Table II), the mean
effective dose per EVAR procedure was 6.2 mSv (range of
values 1.3 to 20 mSv).
The cumulative dose in air, D, ranged between 49 and
898 mGy (Table II) and increased linearly with t and BMI
(n  62, r  0.95, SEE  7.1).
D mGy393 11.4 t (min) 13.35 BMI kg m2
Similar linear relationships were found between eitherDAP or D and time and waist circumference.Film dosimetry showed that the “source-skin” dis-
tance, 65 cm on average, was smaller than the 69.5 cm
distance, where Dwas assessed, free-in-air. Assuming a 35%
dose increase in patient’s skin due to photons backscattered
in the human body4,7-9 and a 27% attenuation of the x-ray
beam at the surgical table (according to the direct measure-
ments), themean and themaximum anticipated cumulative
doses (in water) were 0.30 and 1.01 Gy, respectively.
However, such an approach overestimates the peak skin
doses. Non-overlapping and partially overlapping beam
portals (locations where the beam enters into the human
body) were used. From the other hand, this approach
assumes that the dosimetric parameters provided by the
fluoroscopy units are accurate.
In vivo dosimetry, carried out in a subgroup of patients
with DAP and D values representative of the entire group,
showed that the peak skin dose, Dpeak, increased linearly
with D (r  0.976, SEE  33).
Dpeak mGy 0.86 D Gy cm2
Therefore, the mean and the maximum peak skin doses
were 227 and 773 mGy, respectively, ie, about 30% lower
than the calculated peak skin doses based on the registered
cumulative dose values.
CT angiography. CT angiographs (two-phase an-
giography before repair, and a single-phase within the first
month after repair) contribute to the same skin area an
additional dose of 50 mGy. Therefore, the mean and the
maximum peak skin doses within a short time period were
0.28 and 0.82 Gy, respectively. This finding is in accordance
with the clinical observation of absence of any radiation-
related deterministic skin reactions in the studied group of
patients.
DISCUSSION
Fluoroscopic imaging is extensively used in interven-
tional procedures, such as EVAR, to localize the lesion,
monitor the procedure, and control and document the end
result. Procedures requiring large fluoroscopy times are
associated with a significant radiation hazard. Therefore,
quantities that can be assessed easily, such as fluoroscopic
time, the DAP and D, should be evaluated and recorded in
the patient’s file. Patient size and procedural aspects, such
as the location(s) of the beam, beam angle, distance of the
patient’s skin from the x-ray tube, type of x-ray unit used,
size of the radiation field, irradiation mode (normal or high
Table II. Dosimetric parameters (n  62)
Parameter
DAP
(Gy cm2)
Cumulative
dose (Gy)
Fluoroscopy
time (min)
Area
(cm2)
Mean value 42.5 0.264 22.6 167.0
Median value 37.4 0.220 18.0 179.4
Standard deviation 25.6 0.175 14.3 21.0
Range of values 9-139 0.05-0.90 4.3-75 97-181
DAP, Dose area product.dose continuous dose rate, pulse rate during both fluoros-
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the tube and the patient’s skin are factors that influence the
radiological burden.
The mean fluoroscopy time found in the present study,
22.6 minutes, was comparable or lower than the mean
values of 39.4, 28.4, 23.7, and 21 minutes reported by
Lipsitz, Geijer, Ferrar, and Weerakkody, but higher than
the 13.0 minutes reported by Ho et al.6,10-13 The mean
DAP value found in the present study, 42.5 Gy cm2, was in
between the 34 and 84 cm2 mean values for coronary
angiography and angioplasty at IUH during the study
period. The median DAP value, 37.4 Gy cm2, was lower
than the 150 and 60.1 Gy cm2 median values reported by
Weerakkody12 and Geijer,6 respectively. In this compari-
son, one has to take into account that Weerakkody et al
excluded from their analysis7% of the carried procedures,
that resulted in values several orders of magnitude greater
than the typical values recorded. Moreover, the median
effective dose, 27 mSv, was about four times higher than
the one found in the present study, 6.2 mSv, neglecting
beam attenuation in the surgical table and mattress. The
calculated peak skin dose ranged between 0.51 to 3.74 Gy,
with amedian value of 0.85Gy, (the 2Gy threshold for skin
damage was exceeded in 27% of the patients) vs 0.19 Gy in
the present study. In addition, the effective dose due to
the three CT scans carried out at IUH during the first
year after the EVAR procedure resulted in an effective
dose of 33 mSv, almost 40% of the effective dose reported
byWeerakkody et al, 79mSv, mainly due to the elimination
of the unenhanced phase in the present study.
Stochastic risks. The procedure-related 6.2 mSv
mean effective dose, a quantity assumed to be proportional
to the probability for induction of stochastic effects, was
between the mean doses related to planar coronary angiog-
raphies and angioplasties at IUH, 5.5 and 15 mSv, respec-
tively. However, EVAR patients in practice receive higher
radiation burden than patients with severe coronary artery
stenosis, due to the procedure-associated CT aortogra-
phies. The two-phase preoperational CT abdominal/pelvic
angiography carried out at IUH, adds an effective dose of
22 mSv, while the three single-phase enhanced aortogra-
phies prescribed during the first post-EVAR year require a
total dose of about 33 mSv. Therefore, patients are getting
within a single year an effective dose of about62 mSv, ie,
30 times higher than that received annually from natural
background radiation in most of the countries. Assuming
that a risk factor of 4% per Sv can be used (a value obtained
by matching the age distribution data of the present study
with the excess lifetime mortality data of the American
National Academic of Science),14 the excess mortality due
to radiation-induced carcinogenesis from the procedures
carried out during the first year was estimated to be 1 per
400. Under the assumption that the follow-up period is
extended up to 10 years post-procedure with a single-phase
CT angiography annually, the repair and its surveillance
(pre-EVAR CT angiography, endovascular procedure, and
12 post-EVAR CT angiographies) induce a total effectivedose of 160 mSv, corresponding to excess mortality of 1
per 155.
Deterministic risks. The skin, the largest tissue of the
body, is irradiated non-uniformly, and some of its sections
may receive high doses. Although there are some reports on
radiation-induced basal cell and squamous cell skin can-
cers,4 skin sensitivity for stochastic effects is considered to
be low.1,2 On the contrary, the thresholds for skin reac-
tions are relatively low. Both mild and severe iatrogenic
skin injuries have been reported in patients undergoing
fluoroscopically-guided procedures,4,5 mainly as a result
of the use of inappropriate equipment and poor opera-
tional techniques. In the present study, the maximal peak
skin dose assessed in the studied group of patients, 0.82 Gy
within a short time period, was almost half of the threshold
for transient erythema.
The use of the indications provided by the fluoroscopic
unit, D and DAP, for the calculation of the peak skin dose
introduces in practice large errors, such as inaccuracies
related to the calibration of the meter with beam spectra
similar to those used during clinical practice, attenuation of
the photon beam in the surgical table and the mattress, use
of more than one irradiation ports, uncertainties in the
exact focus to skin distance, and the values of the backscat-
tering factors to be used. According to the present study,
peak skin doses to individual patients treated at IUH can be
assessed under daily clinical conditions indirectly based on
the cumulative dose in air provided by the fluoroscopic unit
(Fig). However, the 15% numerical difference between
the peak skin dose and D found in the present study is
applicable only under conditions similar to those in the
present study. For example, use of a different type of
surgical table than the one used in the present study (it
causes a 28% dose reduction at 81 kV beams) and different
focus to skin distance, may modify this value.
Taking into account that additional procedures might
be required to be carried out in EVAR patients within a
short time period exposing the same skin area, dosimetric
data have to be recorded in the patient’s file. In those
patients that the EVAR-related cumulative dose, D, ex-
ceeds 1.1 Gy, patient follow-up procedures are carried out
at IUH to address the potential for serious skin injuries
according to the recommendations of the International
Commission on Radiological Protection.4
CONCLUSION
Justification and optimization of the strategies used for
the treatment of aortic aneurysmsmust commensurate with
the medical purpose. The moderate radiation exposure due
to an EVAR procedure is coupled with substantial exposure
due to CT angiographies, according to the recently pro-
posed characterizations of the various procedures by the
International Commission on Radiological Protection.1 In
addition to the radiation-related risk for carcinogenesis, the
induction of harmful skin injuries has to be considered,
mainly in obese EVAR patients undergoing additional pro-
cedures, such as a coronary angioplasty closely spaced in
time with EVAR. The size of the radiation burden related
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 2 Clair 287to the treatment and the follow-up calls for further investi-
gations on strategies to reduce the radiological risk as low as
reasonably achievable consistent with the medical need.
The optimum strategy in each facility has to be studied and
justified based on solid clinical and radiobiologic evidences.
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Endovascular repair of abdominal aortic aneurysm (AAA) has
afforded patients significant benefit over open repair of AAA by
measures of standard risks associated with aneurysm repair. How-
ever, the adoption of this form of repair for most AAAs has brought
with it new risks that remain yet to be fully defined. These addi-
tional risks include endoleaks, endotension, and the potential of
device failure. Importantly, these risks can be identified with care-
ful follow-up and quantified when describing the performance of
the procedure to patients.
The procedure also brings with it, however, the risk of the
radiation burden imposed by the preoperative assessment, the
intraoperative use of fluoroscopy, and the continuing radiation
burden related to radiographic imaging to assess the graft and its
function over time. The intraoperative radiation risks are not
exclusive to the patient, but affect the surgeon and the operative
team as well. Identifying the radiation burden, the related clinical
variables, and the timing of this radiation burden is important in
any attempt to reduce these risks for both patient and staff.
Kalef-Ezra et al, in the current study, have evaluated the
radiation burden incurred by patients undergoing endovascular
aneurysm repair. Although their main focus was the radiation
burden during the performance of the procedure, the study also
assessed the additional risk from the continued assessment in
follow-up. This overall risk is not insignificant: in the first year
alone, the patients undergoing endovascular aneurysm repair aver-
aged a dose close to 30 times the average annual background
radiation to which individuals are normally exposed, and thistained three times in the first year. The amount of exposure during
the procedure itself averaged less than half the presumed necessary
amount for radiation to induce erythematous skin changes and
appears to be significantly less than that accumulated during the
routine follow-up with CT scan. However, this intraoperative
amount coupled with the dosing obtained from preoperative and
long-term follow-up leads to a considerable radiation exposure.
The authors noted two direct correlates to increased radiation
dose: body-mass index and fluoroscopy time.
As the complexity of endovascular repair and the proportion of
vascular surgical procedures performed with fluoroscopy increases,
we need to be cognizant of the increasing radiation exposure to our
patients, our staff, and ourselves. The current study highlights the
importance of fluoroscopy time in relation to radiation exposure.
All surgeons performing these procedures need to devote their
efforts to minimizing fluoroscopy time, thereby reducing exposure
to all present in the room. Increased size of the patient and
increased complexity and time for the repair, in particular, pose
intraoperative risk for high-dose radiation exposure and potentially
for radiation-induced skin changes.
In addition, the total radiation burden borne by the patient
determines his or her overall risk, and methods to reduce this
burden need to be developed to ensure that we are not exposing
our patients to unnecessary risks. Evaluation of methods to reduce
the overall radiation burden should involve reducing the doses
achieved during the preoperative assessment study, operative pro-
cedure, and the long-term follow-up evaluation to minimize radi-
ation exposure.
